Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 

      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Dobutamine Hcl Taj Pharmaceuticals Ltd.

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Dobutamine Hcl Manufacturers in India Suppliers Dobutamine Hcl Dossage Exporters Distributors Dobutamine Hcl api active pharmaceuticals ingredients Dobutamine Hcl manufacturers Side Effects bulk drugs raw material Dossage Dobutamine Hcl companies Side Effects Dossage Importers Dobutamine Hcl Dossage Dobutamine Hcl Exporters Dobutamine Hcl exporters Dossage FDA Dossage Dobutamine Hcl Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Dobutamine Hydrochloride manufacturing pharmaceutical drugs pharmaceutical intermediates Dobutamine Hydrochloride pharmaceutical chemicals pharmaceutical raw materials Dobutamine Hydrochloride active pharmaceutical ingredients Dobutamine Hydrochloride committee active pharmaceutical ingredients manufacturer Dobutamine Hydrochloride Active Pharmaceutical Ingredients manufacturer Dobutamine Hydrochloride exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Dobutamine Hcl, Dobutamine Hcl manufacturer India, Dobutamine Hcl product, Dobutamine Hcl products, Api preparation, Certificate of Analysis API manufacturer product, Dobutamine Hcl anti ulcer product, Certificate of Origin COA Dobutamine Hcl COS Dobutamine Hcl, pharmaceutical generic, pharmaceutical drug, medical, Dobutamine Hcl pharma healthcare, pharma patents, contract MSDS manufacturing Trader Dobutamine Hcl pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Dobutamine Hcl expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Dobutamine Hcl DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Dobutamine Hcl ingredients, api, HIV Dobutamine Hcl, tablets, capsules, syrup & protein Dobutamine Hcl powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Dobutamine Hcl gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Dobutamine Hcl WHO, UKMHRA Approval

   API >>>
   Pharmaceuticals API List
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us

CAS Number 52663-81-7






HOME >> API >> API List1 >> Dobutamine Hcl >> Dosage

Dobutamine Hcl CAS Number 52663-81-7

Dobutamine CAS Number 49745-95-1

Note: Do not add dobutamine to 5% Sodium Bicarbonate Injection or to any other strongly alkaline solution. Because of potential physical incompatibilities, it is recommended that dobutamine not be mixed with other drugs in the same solution. Dobutamine should not be used in conjunction with other agents or diluents containing both sodium bisulfite and ethanol.

Preparation and Stability

At the time of administration, dobutamine must be further diluted in an IV container to at least a 50-mL solution using one of the following intravenous solutions as a diluent: 5% Dextrose Injection, 5% Dextrose and 0.45% Sodium Chloride Injection, 5% Dextrose and 0.9% Sodium Chloride Injection, 10% Dextrose Injection, lsolyte® M with 5% Dextrose Injection, Lactated Ringer's Injection, 5% Dextrose in Lactated Ringer's Injection, Normosol® M in D5-W, 20% Osmitrol® in Water for Injection, 0.9% Sodium Chloride Injection, or Sodium Lactate Injection. Intravenous solutions should be used within 24 hours.

Recommended Dosage

Infusion of dobutamine should be started at a low rate (0.5-1.0 µg/kg/min) and titrated at intervals of a few minutes, guided by the patient's response, including systemic blood pressure, urine flow, frequency of ectopic activity, heart rate, and (whenever possible) measurements of cardiac output, central venous pressure, and/or pulmonary capillary wedge pressure. In reported trials, the optimal infusion rates have varied from patient to patient

Information Associated with Product:
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Dobutamine Hcl

Api Manufacturing At Taj

Acamprosate Calcium

Clomipramine Hcl

Alendronate Sodium



Clopidogrel Bisulfate



Atomoxetine Hcl



Desmopressin Monoacetate


Divalproex Sodium


Dobutamine Hcl

Bupropion Hcl



Dothiepin Hcl






Escitalopram HBr





Cefuroxime Axetil



Fluticasone Propionate

Citalopram Hbr

Fluvoxamine Maleate

Fosphenytoin Sodium

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap


taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.